There was no significant difference between Ki-67 levels in dogs with metabolic disorders, neurological disorders, inflammatory conditions, or organ failure (p = 0.11), with the exception of a significantly higher Ki-67 concentration in dogs with inflammatory diseases compared to dogs with neurological disorders (p = 0.02, Figure 1A). This evidence concerns the gene MKI67 and metabolic disease.